TUBD1

Across TCGA pan-cancer cohorts, TUBD1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated TUBD1 data layer compared with 4 for mutation status.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher TUBD1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TUBD1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and LUSC show a favorable association.

LIHC, KIRC, and LUSC are the cancer types where TUBD1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	All	0.705	0.844	<.001	84	view →
KIRC	OS	Quartile	All	0.886	0.754	<.001	78	view →
LUSC	OS	Quartile	II,III,IV	0.829	0.295	.002	46	view →
ACC	DFS	Median	All	0.259	0.603	.001	42	view →
LGG	OS	Median	All	0.344	0.550	<.001	41	view →
MESO	DFS	Median	IV	0.172	0.485	.002	40	view →
HNSC	DFS	Median	IV	0.711	0.568	.003	38	view →
KICH	DFS	Quartile	II,III,IV	0.502	1.000	.006	34	view →
UCS	OS	Median	II,III,IV	0.776	0.444	.004	34	view →
KIRP	DFS	Quartile	II,III,IV	0.202	0.879	.003	30	view →
SKCM	OS	Quartile	All	0.379	0.256	.001	27	view →
READ	OS	Median	All	0.803	0.494	.006	26	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

TUBD1–LIHC (OS)

Open the LIHC breakdown →